Bulgaria Pharmaceuticals & Healthcare Q4 2018
Due to perennial underperformance relative to its European peers, the Bulgarian healthcare sector is on the cusp of aradical overhaul. Boosting trade with China as well as regional partners, and an overhaul of its drug reimbursement system will formthe core of government reforms to raise healthcare standards. Despite this, the investment climate formultinational pharmaceutical firms is expected to remain challenging with both socioeconomic and industry-specific factors posingheadwinds to growth.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook